Onyia Jude — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Onyia Jude has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $14.22M.

Profile

Onyia Jude

Jude Onyia is the Chief Scientific Officer at Neurocrine Biosciences Inc, a company focused on developing treatments for neurological and endocrine disorders. He has been involved in multiple SEC filings related to his role, indicating active participation in the company's scientific endeavors.

RoleDirector
Notability20/100

Board memberships

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-09NBIXNEUROCRINE BIOSCIENCES INCG — Bona-fide gift2.4K$0.00
2026-06-02NBIXNEUROCRINE BIOSCIENCES INCS — Open-market sale11.0K$160.25$1.76M
2026-06-02NBIXNEUROCRINE BIOSCIENCES INCM — Option exercise11.0K$84.74$932K
2026-05-29NBIXNEUROCRINE BIOSCIENCES INCS — Open-market sale11.0K$155.53$1.71M
2026-05-29NBIXNEUROCRINE BIOSCIENCES INCM — Option exercise11.0K$84.74$932K
2026-02-24NBIXNEUROCRINE BIOSCIENCES INCG — Bona-fide gift3.1K$0.00
2026-02-17NBIXNEUROCRINE BIOSCIENCES INCF — Tax withholding / forfeiture10.8K$124.12$1.33M
2026-02-17NBIXNEUROCRINE BIOSCIENCES INCA — Grant or award19.9K$0.00
2026-02-17NBIXNEUROCRINE BIOSCIENCES INCF — Tax withholding / forfeiture1.5K$124.12$182K
2026-02-17NBIXNEUROCRINE BIOSCIENCES INCM — Option exercise2.7K$0.00
2026-02-17NBIXNEUROCRINE BIOSCIENCES INCF — Tax withholding / forfeiture1.5K$124.12$180K
2026-02-17NBIXNEUROCRINE BIOSCIENCES INCM — Option exercise2.7K$0.00
2026-02-17NBIXNEUROCRINE BIOSCIENCES INCF — Tax withholding / forfeiture1.4K$123.10$176K
2026-02-17NBIXNEUROCRINE BIOSCIENCES INCM — Option exercise2.6K$0.00
2026-02-03NBIXNEUROCRINE BIOSCIENCES INCF — Tax withholding / forfeiture142$136.06$19K
2026-02-03NBIXNEUROCRINE BIOSCIENCES INCM — Option exercise238$0.00
2025-09-03NBIXNEUROCRINE BIOSCIENCES INCG — Bona-fide gift1.5K$0.00
2025-08-05NBIXNEUROCRINE BIOSCIENCES INCG — Bona-fide gift3.1K$0.00
2025-07-09NBIXNEUROCRINE BIOSCIENCES INCS — Open-market sale59.8K$130.46$7.80M
2025-07-09NBIXNEUROCRINE BIOSCIENCES INCM — Option exercise59.8K$84.74$5.07M

Companies — Last 90 Days

Frequently Asked Questions

Who is Onyia Jude?

Jude Onyia is the Chief Scientific Officer at Neurocrine Biosciences Inc, a company focused on developing treatments for neurological and endocrine disorders. He has been involved in multiple SEC filings related to his role, indicating active participation in the company's scientific endeavors.…

How many SEC Form 4 filings has Onyia Jude submitted recently?

4 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Onyia Jude been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 5 open-market sales ($14.22M) across all tracked filings.

Where can I see all of Onyia Jude's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Onyia Jude profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.